Treatment of intestinal strains
Infection of intestinal strains refers to a series of infectious diseases caused by bacteria and its products in the intestinal tract that cross the intestinal barrier and enter the lymphoma of the intestinal membrane, the door vein system and the entire blood circulation, thus seriously threatening the health of the patient. This paper will elaborate on the treatment of intestinal intestinal tumulture transfer infections, including treatment of basic diseases, functional rehabilitation of intestinal barriers, rational use of antibiotics, application of micro-ecological formulations and immunomodification treatments, with the aim of providing a comprehensive reference for clinical treatment to improve patient prognosis.
Introduction
Under normal conditions, intestinal strains are symbiotic with the host and intestinal barriers are effective in preventing bacterial migration. However, under certain pathological factors, such as severe trauma, burns, major surgery, severe infections, long-term use of antibiotics, refilling of intestinal ischaemic lesions, impaired intestinal barrier function, imbalanced intestinal gynaecology, susceptibility to intestinal tumultosis, leading to serious complications such as systemic inflammation syndrome (SIRS), sepsis and multi-organ functional impairment syndrome (MODS), prompt and effective treatment is essential.
II. Treatment of basic diseases
1. Active treatment of primary diseases
In the case of trauma patients, the treatment is done in a timely manner, in a manner that prevents further infection. Open fractures, for example, require surgery to fix fractures as soon as possible, to remove the contaminants and degenerative tissues in the wound, to reduce the risk of infection and to reduce the incentive for intestinal group migration.
In cases of acute pancreasitis, comprehensive treatment measures such as fasting, gastrointestinal decompression, inhibition of incubation, anti-infection, liquid resuscitation should be taken to mitigate pancreasitis, to mitigate the effect of high abdominal pressure on the intestinal tract and the ischaemic condition, thus protecting the intestinal barrier and preventing the movement of the fungal population.
2. Improving the functioning of organs
In cases of combined shock, the blood capacity is rapidly replenished, the state of shock is corrected and the injection of vital organs is maintained. Monitoring indicators such as central intravenous (CVP) and average artery (MAP) can guide the amount and speed of rehydration, ensure blood supply in the intestinal tract, and prevent intestinal mucous barrier damage due to ischaemic infraoxins and the displacement of bacterial population.
In cases of combined respiratory failure, support is provided in a timely manner, such as oxygen therapy, mechanical ventilation, to correct low oxygen haematosis, to improve overall oxygen metabolism, to mitigate the adverse effects of tissue deficiency on the intestinal tract, and to reduce the potential for intestinal mass transfer.
III. intestinal barrier functional restoration
1. Nutritional support
Early initiation of intestinal nutrition support and selection of suitable nutrient formulations, such as intestinal nutrient formulations with dietary fibres, azinamides and acrylic acids. Dietary fibres can be used for the decomposition of intestinal bacteria, producing short-chain fatty acid, providing energy to intestinal mucous cells and maintaining the normal structure and functioning of intestinal mucous membranes; aluminumamine is an important energy material for intestinal mucous cells, helping to repair damaged intestinal mucous membranes; and acre acid enhances the immune function of the organism and contributes to the maintenance of the intestinal barrier.
In cases where intestinal nutrition does not meet the patient ‘ s nutritional needs or the patient ‘ s intestinal function is not restored, co-intestine support may be provided, but care should be taken to avoid long-term overdependence on intestinal nutrition and to prevent intestinal mucous membrane atrophy and barrier loss.
2. Application of intestinal mucosa protection
Drugs commonly used are sulfur aluminum, demolite, etc. Sulphur aluminum forms gels under gastric acid, covering the intestinal mucous membrane surface, which protects the mucous membrane, reduces bacterial adhesion and transfer; demolite skeletal distillation has a lacquer structure and an uneven charge distribution, which fixes and inhibits viruses, fungi and the toxins they produce in the digestive tract, while repairing, improving the defensive function of the mucous membrane barrier, reducing the damage to the intestinal mucous membrane and reducing the risk of the displacement of the fungal population.
IV. Rational use of antibiotics
1. Precision choice of antibiotics
Based on the results of bacterial culture and drug sensitivity tests, sensitive antibiotics are selected for targeted treatment. Before the drug sensitivity results are obtained, the experiential choice of broad-spectral antibiotics that cover the gebracic and anaerobic bacteria, such as the third generation of cystactin combined nitromepazole-type drugs, should avoid the abuse of antibiotics, prevent further disarray of intestinal strains and increase the displacement of bacterial strains.
2. Reasonable determination of course of treatment
The course of treatment for the use of antibiotics should be determined on the basis of a combination of the patient ‘ s condition, the area of infection and the type of pathogens. The treatment process may need to be extended, as appropriate, to ensure that the infection is fully controlled, while closely monitoring changes in intestinal strains and adjusting treatment programmes in a timely manner, for patients with low immune functions, with deep tissue infections or who are unable to get rid of them.
V. Micro-ecological formulation applications
1. Vegetable bacteria
Adding good fungus, acidic emulsions, fascinos, etc. can regulate the intestinal community balance, inhibit the growth and reproduction of harmful bacteria, enhance the intestinal mucous barrier and reduce bacterial transfer. Bountiful bacterial formulations can be administered through oral, enema, for example, double bacterium quadriforms, oral implantation in the intestinal tract, improvement of intestinal microecological environment, and prevention and treatment of intestinal strains.
2. Life expectancy
For example, low-polymers, as well as pyrenics, can selectively stimulate the growth and reproduction of beneficial bacteria in the intestinal tract, provide a nutrient base for the fungi and promote the planting and metabolism of the fungi in the intestinal tract, thus indirectly acting to improve the intestinal mass structure, enhance the intestinal barrier function and reduce the incidence of intestinal strain transmissible infections, often applied in conjunction with the fungi to improve the treatment.
VI. Immunological regulation treatment
1. Immuno-enhancement
Immunostatic boosters, such as mammograms, protein, etc., are appropriate for patients with low immune functions. The lymphocyte promotes the separation, maturity and immunoactivity of T lymphocyte cells and enhances the cytoimmuno-immunology of the organism; the C-ball protein contains a variety of antibodies, improves body fluid immunosupulation of the organism, enhances the resistance of the organism to pathogens and contributes to the prevention and control of all-infective diseases caused by intestinal group movements.
2. Inflammatory media constraint agent
In cases of over-activation of the inflammatory response, the use of inflammatory media such as tumour cause of death-alpha (TNF-alpha) stressor, white cellulin-6 (IL-6) stressor may be considered in order to mitigate the overall inflammation response, prevent damage to the organ function caused by the inflammation of the inflammation, and help to stabilize the intestinal barrier function and reduce the incidence of intestinal morbidity, provided that the application of such drugs is strictly controlled with adaptive certificates and dosages and avoid excessive suppression of the immune function.
Concluding remarks
The treatment of intestinal strains is an integrated process that requires individualized treatment programmes for the specific conditions of patients, focusing on a number of measures, including treatment of basic diseases, repair of intestinal barriers, rational use of antibiotics, application of micro-ecological agents and immuno-regulating treatment, in order to effectively control infections, restore micro-ecological balance in the intestinal tract, reduce the incidence of complications and mortality, and improve the quality of life and the prognosis of patients. At the same time, changes in the patient ‘ s condition should be closely monitored during the treatment process and the treatment strategy adjusted in time for optimal treatment.
